Weakness and atrophy of the quadriceps and hamstrings is a common problem in patients who have noteworthy chronic osteoarthritis and after major operations such as anterior cruciate ligament (ACL) reconstruction.^[@bibr6-1941738118811337],[@bibr19-1941738118811337],[@bibr44-1941738118811337]^ Patients with patellofemoral or tibiofemoral arthritis may have difficulty achieving strength gains even with formal rehabilitation due to pain incurred with heavy-load resistance exercises.^[@bibr8-1941738118811337],[@bibr32-1941738118811337],[@bibr45-1941738118811337]^ The American College of Sports Medicine recommends a minimum resistance training load of 60% to 70% of 1 repetition maximum (1 RM) to gain strength and 70% to 85% of 1 RM to achieve muscle hypertrophy.^[@bibr1-1941738118811337]^ Training with these high loads may not be possible or may even be deleterious in painful arthritic knees. Many studies have reported lingering quadriceps weakness many months or even years after ACL reconstruction that impairs return to normal function.^[@bibr16-1941738118811337],[@bibr30-1941738118811337]^ This occurs despite the immediate implementation of physical therapy and preventative measures such as electrical muscle stimulation, early weightbearing, and use of both closed and open kinetic chain exercises. With the focus of surgery and rehabilitation targeting return to preinjury sports activity levels in many investigations, the prevention of muscle atrophy and early recovery of muscle strength and neuromuscular function are considered paramount for athletic patients.^[@bibr2-1941738118811337],[@bibr3-1941738118811337],[@bibr28-1941738118811337]^

Recently, studies have begun to explore the use of blood flow--restricted training (BFRT) with low-resistance loads (such as 30% of 1 RM) in individuals who cannot tolerate high-load resistance training ([Figure 1](#fig1-1941738118811337){ref-type="fig"}). Many investigations have shown a positive benefit of BFRT in healthy participants and athletes^[@bibr21-1941738118811337],[@bibr23-1941738118811337],[@bibr36-1941738118811337],[@bibr41-1941738118811337]^ and in elderly individuals.^[@bibr7-1941738118811337],[@bibr31-1941738118811337],[@bibr33-1941738118811337],[@bibr39-1941738118811337],[@bibr46-1941738118811337],[@bibr48-1941738118811337]^ Various hypotheses for the potential effectiveness of BFRT in increasing muscle strength and hypertrophy have been proposed. Hughes et al^[@bibr13-1941738118811337]^ hypothesized that an ischemic and hypoxic muscular environment is generated during BFRT that causes high levels of metabolic stress and mechanical tension when exercise is combined with training. Metabolic stress and mechanical tension have been theorized to activate various mechanisms that induce muscle growth, such as elevated systematic hormone production, cell swelling, production of reactive oxygen species, intramuscular anabolic/anticatabolic signaling, and increased fast-twitch fiber recruitment.

![Examples of blood flow restriction exercise training that may be done nonweightbearing, such as (a) during knee extension, or weightbearing, such as (b) during partial squatting.](10.1177_1941738118811337-fig1){#fig1-1941738118811337}

Hughes et al^[@bibr13-1941738118811337]^ systematically reviewed 20 studies in which BFRT was used for clinical musculoskeletal rehabilitation. These authors concluded that low-load BFRT had a moderate effect on increasing strength but was less effective than heavy-load training. This review contained a wide variety of studies involving ACL reconstruction, knee osteoarthritis, older adults at risk for sarcopenia, and patients with sporadic inclusion body myositis. All types of upper and lower body BFRT were included, such as elastic band resistance training, low- to moderate-intensity walk training, body weight exercises, and low-load resistance training. Because of the heterogenic nature of this review, the effect of low-load resistance BFRT on muscle weakness and atrophy specifically related to knee pathology remains uncertain.

The purposes of this systematic review were to determine whether BFRT is effective in (1) improving quadriceps and hamstrings strength and cross-sectional area (CSA) for chronic knee-related lower extremity muscle atrophy and (2) preventing muscle atrophy after knee surgery.

Methods {#section10-1941738118811337}
=======

Literature Search Strategy {#section11-1941738118811337}
--------------------------

The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed in conducting this study.^[@bibr20-1941738118811337]^ An online search was performed using PubMed for all years through 2017 and the key phrases and words *blood flow restriction training, blood flow restricted exercise, occlusion resistance training, KAATSU training*, and *low load resistance training*. The full text was accessed if the abstract suggested that this might be a clinical study in the topic of interest. In addition, reference lists from general review articles, systematic reviews, and meta-analyses obtained from the search were examined to find any other original research investigations not otherwise obtained.

Study Selection and Quality Assessment {#section12-1941738118811337}
--------------------------------------

To be included in the review, studies were required to be a controlled trial (randomized or nonrandomized), be published in English, use BFRT either to treat chronic lower extremity muscle atrophy or to prevent muscle atrophy after a knee operation, and report a measured effect of BFRT on quadriceps and/or hamstrings muscle strength or CSA.

Exclusion criteria included studies that (1) were off-topic; (2) investigated the acute effects of BFRT (ie, after 1 training session); (3) included trained healthy participants; (4) concerned trained patients with cardiovascular disease, obesity, or polymyositis; (5) included trained elderly patients; (6) included trained patients after voluntary immobilization; (7) included trained upper body muscles; and (8) did not provide measurement of quadriceps or hamstrings strength or CSA. General or systematic reviews, meta-analyses, editorials, case series, case reports, and laboratory animal studies were also excluded.

Study quality was evaluated using the Physiotherapy Evidence Database (PEDro) scale^[@bibr27-1941738118811337]^ for randomized investigations or the Methological Index for Non-Randomized Studies (MINORS) criteria for nonrandomized controlled trials.^[@bibr40-1941738118811337]^ The MINORS score is reported as a percentage of the total available points, as recommended by Wylie et al.^[@bibr47-1941738118811337]^

Data Extraction {#section13-1941738118811337}
---------------

The following data were extracted from each article when available: study design, sex, age, diagnosis, number of training sessions, cuff pressure, occlusion protocol, exercise protocol, quadriceps and hamstrings strength measurements (isokinetic, isometric, or maximum leg press), CSA measurements for quadriceps and hamstrings using magnetic resonance imaging (MRI) or ultrasound, results of muscle biopsy, data from clinical outcome instruments, and information related to pain or discomfort during training. Effect sizes (ESs) were calculated when the data were available according to Cohen^[@bibr5-1941738118811337]^ and were interpreted as small effects (≤0.2), moderate effects (0.5), and large effects (≥0.8).

Results {#section14-1941738118811337}
=======

The search identified 534 articles, of which 525 were excluded ([Table 1](#table1-1941738118811337){ref-type="table"}), leaving 9 studies for our review. The average PEDro score in the 8 level 1 randomized studies^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr11-1941738118811337],[@bibr17-1941738118811337],[@bibr29-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337],[@bibr42-1941738118811337],[@bibr43-1941738118811337]^ was 8 (range, 6-10), and the MINORS score in the 1 nonrandomized level 2 study^[@bibr42-1941738118811337]^ was 79%.

###### 

Reasons for 525 articles excluded

![](10.1177_1941738118811337-table1)

  Exclusion Criteria                                       Articles, n
  -------------------------------------------------------- -------------
  Off-topic                                                205
  Acute effects training                                   92
  Training in healthy participants or athletes             55
  Physiology-based study                                   38
  General review                                           28
  Upper body training                                      22
  Training in elderly patients                             22
  Case report or series                                    12
  Study effect of cuff pressure                            11
  Editorial                                                11
  Systematic review/meta-analysis                          8
  Laboratory (animal) study                                7
  Effects training after immobilization                    5
  Study protocol only (no results)                         4
  Study diseases (cardiovascular, obesity, polymyositis)   4
  Survey                                                   1

The effect of BFRT in preventing muscle atrophy after knee operations was assessed in 3 studies after ACL reconstruction^[@bibr17-1941738118811337],[@bibr29-1941738118811337],[@bibr42-1941738118811337]^ and in 1 study after routine knee arthroscopy^[@bibr43-1941738118811337]^ ([Table 2](#table2-1941738118811337){ref-type="table"}). BFRT was used to treat chronic muscle weakness due to knee osteoarthritis in 4 studies^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ and patellofemoral pain in 1 study.^[@bibr11-1941738118811337]^ BFRT was used in 165 patients (93 women, 72 men) whose mean age was 42.2 years. There were 170 control participants (100 women, 70 men) whose mean age was 40.6 years.

###### 

Study protocols

![](10.1177_1941738118811337-table2)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                            Study Group                                        Protocol                                                                                                                                                                                                                                                                                 
  ------------------------------------------------------------------------- ------------------------ ------------------------- ------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ohta et al^[@bibr29-1941738118811337]^ (1), ACL reconstruction            19 males\                12 males\                 2×/day\                         Air tourniquet, 180 mm Hg                                                                                                                                           Inflate duration of training, maximum 15 min. Remove 15-20 min, resume if required   Straight-leg raises, hip abduction and adduction isometrics, quadriceps isometrics, half-squats, step-ups, walk in deep flexion, elastic tube squat resistance. 20 reps 2×/day
                                                                            9 females\               10 females\               weeks 2-16 p.o.\                                                                                                                                                                                                                                                                         
                                                                            Mean age, 30.0 ± 9.7 y   Mean age, 28.0 ± 9.7 y    (210), at home                                                                                                                                                                                                                                                                           

  Takarada et al^[@bibr42-1941738118811337]^ (2), ACL reconstruction        4 males\                 4 males\                  2×/daydays 1-15 p.o.\           Pneumatic cuff width 9 cm, length 70 cm. 180 mm Hg, gradually elevated 10 mm Hg depending on patient tolerance (range, 200-260 mm Hg). Placebo cuff control group   Inflate 5 min, deflate 3 min, repeat 5×                                              None
                                                                            4 females\               4 females\                (30), in hospital                                                                                                                                                                                                                                                                        
                                                                            Mean age, 22 ± 0.9 y     Mean age, 23 ± 1.0 y                                                                                                                                                                                                                                                                                               

  Iversen et al^[@bibr17-1941738118811337]^ (1), ACL reconstruction         7 males\                 7 males\                  2×/day\                         Delphi low-pressure cuff, 14-cm wide. 130 mm Hg, increased 10 mm Hg, maximum 180 mm Hg                                                                              Inflate 5 min during exercise, deflate 3 min, repeat 5×                              Quadriceps isometrics, leg extensions over knee roll, straight-leg raises. 20 reps each × 5 per session
                                                                            5 females\               5 females\                days 2-16 p.o. (30), at home                                                                                                                                                                                                                                                             
                                                                            Mean age, 24.9 ± 7.4 y   Mean age, 29.8 ± 9.3 y                                                                                                                                                                                                                                                                                             

  Tennent et al^[@bibr43-1941738118811337]^ (1), routine knee arthroscopy   7 males\                 5 males\                  12 sessions\                    Easy-Fit Tourniquet cuff, size varied based on thigh size. Set to 70% of total arterial occlusal pressure                                                           Inflate during exercise, maximum 5 min                                               30% 1 RM BFRT: leg press, knee extension, reverse press, 1 set 30 reps, 3 sets 15 reps\
                                                                            3 females\               2 females\                weeks 3-9 p.o.\                                                                                                                                                                                                                                                                          Exercises for controls not detailed
                                                                            Mean age, 37.0 y         Mean age, 27.0 y          (12), in clinic                                                                                                                                                                                                                                                                          

  Segal et al^[@bibr37-1941738118811337]^ (1), knee osteoarthritis          19 males\                22 males\                 3×/wk × 4 wk\                   Kaatsu Master BFR device, width 6.5 cm, length 65 cm. 160-200 mm Hg, gradually increased during training sessions                                                   Inflate 5 min during exercise, deflate 1.5 min rest between sets                     30% 1 RM both groups: leg press, 1 set 30 reps, 3 sets 15 reps
                                                                            Mean age, 58.4 ± 8.7 y   Mean age, 56.1 ± 7.7 y    (12), in clinic                                                                                                                                                                                                                                                                          

  Segal et al^[@bibr38-1941738118811337]^ (1), knee osteoarthritis          19 females\              21 females\               3×/wk × 4 wk\                   Kaatsu Master BFR device, width 6.5 cm, length 65 cm. 160-200 mm Hg, gradually increased during training sessions                                                   Inflate 5 min during exercise, deflate 1.5 min, rest between sets                    30% 1 RM both groups: leg press, knee extension, reverse press, 1 set 30 reps, 3 sets 15 reps
                                                                            Mean age, 56.1 ± 5.9 y   Mean age, 54.6 ± 6.9 y    (12), in clinic                                                                                                                                                                                                                                                                          

  Bryk et al^[@bibr4-1941738118811337]^ (1), knee osteoarthritis            17 females\              17 females\               3×/wk × 6 wk(18), in clinic     Cuff details NA. 200 mm Hg                                                                                                                                          Inflate during quadriceps exercises (time NA)                                        30% 1 RM BFRT, 70% 1 RM controls: knee extension machine. BFRT 3 sets 30 reps, controls 3 sets 10 reps
                                                                            Mean age, 62.3 ± 7.0 y   Mean age, 60.4 ± 6.7 y                                                                                                                                                                                                                                                                                             

  Ferraz et al^[@bibr8-1941738118811337]^ (1), knee osteoarthritis          12 females\              HR group:\                2×/wk × 12 wk (24), in clinic   Cuff details NA.\                                                                                                                                                   Inflate during exercises and rest periods                                            30% 1 RM BFRT and LR controls, 80% 1 RM HR controls. 4-5 sets × 10 reps
                                                                            Mean age, 60.3 ± 3.0 y   10 females\                                               Set to 70% of total arterial occlusion pressure. Mean, 97.4 mm Hg                                                                                                                                                                                        
                                                                                                     Mean age, 59.9 ± 4.0 y\                                                                                                                                                                                                                                                                                            
                                                                                                     LR group:\                                                                                                                                                                                                                                                                                                         
                                                                                                     12 females\                                                                                                                                                                                                                                                                                                        
                                                                                                     Mean age, 60.7 ± 4.0 y                                                                                                                                                                                                                                                                                             

  Giles et al^[@bibr11-1941738118811337]^ (1), patellofemoral pain          16 males\                20 males\                 3×/wk × 8 wk\                   Cuff details NA.\                                                                                                                                                   Inflate during exercise (time NA), deflate 30 s, rest between sets                   30% 1 RM BFRT, 70% 1 RM controls: leg press, knee extension. BFRT 1 set 30 reps, 3 sets 15 reps. Controls 3 sets 7-10 reps
                                                                            24 females\              19 females\               (24), in clinic                 Set to 60% of total arterial occlusion pressure. Placebo cuff control group                                                                                                                                                                              
                                                                            Mean age, 28.5 ± 5.2 y   Mean age, 26.7 ± 5.5 y                                                                                                                                                                                                                                                                                             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ACL, anterior cruciate ligament; BFRT, blood flow--restricted training; HR, high resistance; LR, low resistance; NA, not available; p.o., postoperative; reps, repetitions; RM, repetition maximum.

Four studies^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ used power analyses to determine sample sizes, and 2 investigations^[@bibr8-1941738118811337],[@bibr11-1941738118811337]^ calculated ESs in addition to *P* values. Data provided in the investigations allowed the calculation of ES in 2 additional studies.^[@bibr4-1941738118811337],[@bibr29-1941738118811337]^

Occlusion Protocols {#section15-1941738118811337}
-------------------

The vascular occlusion protocols varied in all studies except 2 from the same investigators in which the cuff pressure was gradually increased (from 160-200 mm Hg) during individual training sessions.^[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ Three studies^[@bibr8-1941738118811337],[@bibr11-1941738118811337],[@bibr43-1941738118811337]^ set cuff pressures to a percentage of the total arterial occlusion pressure (60%-70%), 2 studies^[@bibr4-1941738118811337],[@bibr29-1941738118811337]^ set the pressure to 1 value for all patients throughout the duration of the investigation (180-200 mm Hg), and 2 studies^[@bibr17-1941738118811337],[@bibr42-1941738118811337]^ gradually increased the pressure throughout the duration of the investigation. Typically, occlusion was maintained during exercise sets and deflated during rest between sets. Placebo cuffs were used in the control group in 2 studies.^[@bibr11-1941738118811337],[@bibr42-1941738118811337]^

Exercise Protocols {#section16-1941738118811337}
------------------

All studies except 1^[@bibr42-1941738118811337]^ incorporated exercises that were done with vascular occlusion. In 6 investigations,^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr11-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337],[@bibr43-1941738118811337]^ a percentage of 1 RM was selected for lower extremity exercises, and in 2 studies,^[@bibr17-1941738118811337],[@bibr29-1941738118811337]^ low-load training was done, but not according to a percentage of 1 RM ([Table 2](#table2-1941738118811337){ref-type="table"}). While some investigations focused solely on quadriceps strengthening, others included hamstrings exercises. Although not evaluated as part of the BFRT protocol, hip (abduction-adduction side-lying leg raises and Theraband resistance) and gastrocnemius-soleus exercises were also included in 2 studies.^[@bibr4-1941738118811337],[@bibr29-1941738118811337]^

Muscle Strength {#section17-1941738118811337}
---------------

Quadriceps muscle strength was measured isokinetically in 4 studies ([Table 3](#table3-1941738118811337){ref-type="table"}).^[@bibr29-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337],[@bibr43-1941738118811337]^ The BFRT group had significantly greater improvements (measured at 60 deg/s) compared with controls in 3 investigations, with the largest magnitude of improvement noted in the study by Tennent et al.^[@bibr43-1941738118811337]^ Two other studies^[@bibr4-1941738118811337],[@bibr11-1941738118811337]^ measured quadriceps strength isometrically, and although neither of these studies reported a significant between-group difference, both the BFRT and control group had significant within-group improvements.

###### 

Changes in quadriceps strength and muscle cross-sectional area after training^[*a*](#table-fn3-1941738118811337){ref-type="table-fn"}^

![](10.1177_1941738118811337-table3)

+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              | Quadriceps Strength                                                                      | Muscle CSA, Biopsy      |                         |                                                       |                |                       |
+:=============================================================+==========================================================================================+=========================+=========================+=======================================================+================+=======================+
| Ohta et al^[@bibr29-1941738118811337]^\                      | Involved-uninvolved ratios                                                               |                         |                         | MRI CSA I/N ratios (preop: 16 wk postop)              |                |                       |
| ACL reconstruction\                                          |                                                                                          |                         |                         |                                                       |                |                       |
| 16 wk postop                                                 |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  60 deg/s: BFRT, 76% ± 16%; control, 55% ± 17%                                           | NA                      | *P* \< 0.001, ES = 1.4  | Quadriceps: BFRT, 101% ± 11%; control, 92% ± 12%      | NA             | *P* = 0.04, ES = 0.78 |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  180 deg/s: BFRT, 77% ± 13%; control, 65% ± 13%                                          | NA                      | *P* = 0.004, ES = 0.92  | Hamstrings: BFRT, 105% ± 19%; control, 102% ± 23%     | NA             | *P* = NS              |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Isometric: BFRT, 84% ± 19%; control, 63% ± 19%                                          | NA                      | *P* \< 0.001, ES = 1.10 | Diameters type 1, 2 fibers medial vastus lateralis    | NA             | *P* = NS              |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Takarada et al^[@bibr42-1941738118811337]^\                  | Not measured                                                                             |                         |                         | MRI CSA % decrease from 3rd to 14th postop day        |                |                       |
| ACL reconstruction                                           |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |                                                                                          |                         |                         | Quadriceps: BFRT, 9.4% ± 1.6%; control, 20.7% ± 2.2%  | *P* \< 0.05    | *P* \< 0.05,\         |
|                                                              |                                                                                          |                         |                         |                                                       |                | ES = −5.87            |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |                                                                                          |                         |                         | Hamstrings: BFRT, 9.2% ± 2.6%; control, 11.3% ± 2.6%  | *P* \< 0.05    | *P* = NS              |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Iversen et al^[@bibr17-1941738118811337]^\                   | Not measured                                                                             |                         |                         | MRI CSA % decrease from 2nd to 16th postop day        |                |                       |
| ACL reconstruction                                           |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |                                                                                          |                         |                         | Quadriceps: BFRT, 13.8% ± 1.1%; control, 13.1% ± 1.0% | NA             | *P* = NS              |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Tennent et al^[@bibr43-1941738118811337]^\                   | 60 deg/s N·m/kg (% improvement^[*b*](#table-fn4-1941738118811337){ref-type="table-fn"}^) |                         | *P* = 0.03              | Not done                                              |                |                       |
| Knee arthroscopy\                                            |                                                                                          |                         |                         |                                                       |                |                       |
| 9 wk postop                                                  |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT pre: 99.83; post: 211.92 (75%)                                                     | *P* = 0.002             |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control pre: 126.7; post: 171.5 (33.5%)                                                 | *P* = 0.2               |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Segal et al^[@bibr37-1941738118811337]^\                     | 60 deg/s N·m mean increase (% improvement)                                               |                         | *P* = NS                | Not done                                              |                |                       |
| Knee osteoarthritis males\                                   |                                                                                          |                         |                         |                                                       |                |                       |
|                                                              |                                                                                          |                         |                         |                                                       |                |                       |
| 4 wk posttraining                                            |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: --0.1 ± 3.3 N·m (0.4%)                                                            | *P* = NS                |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control: 7.0 ± 3.0 N·m (6.7%)                                                           | *P* \< 0.05             |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              | Leg press 1 RM kg mean increase (% improvement)                                          |                         | *P* = NS                |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: 11.3 ± 14.0 (3.1%)                                                                | *P* = 0.003             |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control: 13.5 ± 16.8 (4.7%)                                                             | *P* \< 0.002            |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Segal et al^[@bibr38-1941738118811337]^\                     | 60 deg/s N·m/kg mean increase                                                            |                         | *P* \< 0.01             | MRI volume % increase                                 |                | *P* = NS              |
| Knee osteoarthritis females\                                 |                                                                                          |                         |                         |                                                       |                |                       |
|                                                              |                                                                                          |                         |                         |                                                       |                |                       |
| 4 wk posttraining                                            |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: 0.07 ± 0.03                                                                       | *P* = 0.02              |                         | Quadriceps: BFRT, 1.3% ±0.80%; control, 0.01% ± 0.73% |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control: −0.05 ± 0.03                                                                   | *P* = 0.05              |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              | Leg press 1 RM kg mean increase                                                          |                         | *P* \< 0.05             |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: 28.3 ± 4.8                                                                        | *P* \< 0.001            |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control: 15.6 ± 4.5                                                                     | *P* = 0.005             |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Bryk et al^[@bibr4-1941738118811337]^\                       | Isometric kg force/kg body weight (% improvement)                                        |                         | *P* = NS                | Not done                                              |                |                       |
| Knee osteoarthritis\                                         |                                                                                          |                         |                         |                                                       |                |                       |
| 6 wk posttraining                                            |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT pre: 23.2 ± 8.4; post: 40.0 ± 0.2 (17%)                                            | *P* = 0.001, ES = 2.83  |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control pre: 24.1 ± 10.1; post: 33.5 ± 12.9 (9%)                                        | *P* = 0.001, ES = 0.81  |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Ferraz et al^[@bibr8-1941738118811337]^ Knee osteoarthritis\ | Leg press 1 RM % improvement                                                             |                         |                         | CT CSA % increase quadriceps                          |                |                       |
| 12 wk posttraining                                           |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: 26%                                                                               | *P* \< 0.0001\          | *P* = 0.0004 vs LR\     |                                                       |                |                       |
|                                                              |                                                                                          | ES = 1.01               | *P* = NS vs HR          |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  High-resistance group: 33%                                                              | *P* \< 0.0001\          | *P* \< 0.0001 vs LR     | BFRT: 7%                                              | *P* \< 0.0001\ | *P* = 0.02 vs LR\     |
|                                                              |                                                                                          | ES = 0.82               |                         |                                                       | ES = 0.39      | *P* = NS vs HR        |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Low-resistance group: 8%                                                                | *P* = NS\               |                         |                                                       |                |                       |
|                                                              |                                                                                          | ES = 0.23               |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              | Knee extension 1 RM % improvement                                                        |                         |                         | High-resistance group: 8%                             | *P* \< 0.0001\ | *P* = 0.007 vs LR     |
|                                                              |                                                                                          |                         |                         |                                                       | ES = 0.54      |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT: 23%                                                                               | *P* \< 0.0001\          | *P* = 0.0005 vs LR\     |                                                       |                |                       |
|                                                              |                                                                                          | ES = 0.86               | *P* = NS vs HR          |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  High-resistance group: 22%                                                              | *P* \< 0.0001\          | *P* = 0.0004 vs LR      | Low-resistance group: 2%                              | *P* = NS\      |                       |
|                                                              |                                                                                          | ES = 0.83               |                         |                                                       | ES = 0.12      |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  LR control: 7%                                                                          | *P* = NS\               |                         |                                                       |                |                       |
|                                                              |                                                                                          | ES = 0.21               |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
| Giles et al^[@bibr11-1941738118811337]^\                     | Isometric N·m (% improvement)                                                            |                         | *P* = NS                | Ultrasound quadriceps size (cm)                       |                | *P* = NS              |
| Patellofemoral pain\                                         |                                                                                          |                         |                         |                                                       |                |                       |
| 8 wk posttraining                                            |                                                                                          |                         |                         |                                                       |                |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  BFRT pre: 131.2 ± 61.9; post: 166.4 ± 59.4 (27%)                                        | *P* \< 0.001, ES = 0.58 |                         | BFTR pre: 7.9 ± 1.3; post: 8.0 ± 1.1                  | NS             |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+
|                                                              |  Control pre: 135.1 ± 55; post: 158.7 ± 57.4 (17%)                                       | *P* \< 0.001, ES = 0.42 |                         | Control pre: 7.7 ± 1.4; post: 7.9 ± 1.2               | NS             |                       |
+--------------------------------------------------------------+------------------------------------------------------------------------------------------+-------------------------+-------------------------+-------------------------------------------------------+----------------+-----------------------+

ACL, anterior cruciate ligament; BFRT, blood flow--restricted training; CSA, cross-sectional area; CT, computed tomography; ES, effect size; HR, high resistance; I/N, involved/noninvolved; LR, low resistance; MRI, magnetic resonance imaging; NA, not available; NS, not significant; RM, repetition maximum.

Data are shown as means ± SDs (when available). Percentage improvement data provided when available. ESs calculated according to Cohen when possible.

When outliers (1 from each group) removed.

Segal et al^[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ determined changes in 1 RM by comparing the pretraining leg press value with that obtained on completion of the investigation. While there was no between-group difference in this value in men with knee osteoarthritis, women with osteoarthritis in the BFRT group had a greater increase compared with controls (mean improvement, 28.3 kg and 15.6 kg, respectively; *P* \< 0.05). Ferraz et al^[@bibr8-1941738118811337]^ determined changes in 1 RM in leg press and knee extension values between the BFRT group and 2 control groups. Patients in the high-resistance control group had similar significant improvements in these values to those in the BRFT group. However, patients in the low-resistance control group failed to significantly improve these strength indices.

Hamstrings strength was measured in only 2 studies.^[@bibr29-1941738118811337],[@bibr43-1941738118811337]^ Ohta et al^[@bibr29-1941738118811337]^ reported that ratios of the involved limb/uninvolved limb showed significant differences between the BFRT and control groups 16 weeks after ACL reconstruction at 60 deg/s (81% ± 14% and 72% ± 15%, respectively; *P* = 0.05; ES, 0.62) and at 180 deg/s (84% ± 18% and 74% ± 12%, respectively; *P* = 0.04; ES, 0.65). Tennent et al^[@bibr43-1941738118811337]^ reported significant improvements in isokinetic hamstrings strength in both the BFRT (99.83-141.68 N·m/kg; *P* = 0.002) and control groups (105.51-132.71 N·m/kg; *P* \< 0.05); however, there was no between-group significant difference. Of note, the BFRT group had a larger deficit in hamstring strength at the onset of the study (approximately 3 weeks postoperatively) compared with the control group (31.09 and 7.77 N·m/kg, respectively).

Muscle CSA {#section18-1941738118811337}
----------

The 3 studies on ACL reconstruction all measured CSA using MRI on completion of BFRT, which varied from 16 days to 16 weeks postoperatively.^[@bibr17-1941738118811337],[@bibr29-1941738118811337],[@bibr42-1941738118811337]^ Ohta et al^[@bibr29-1941738118811337]^ reported a significant between-group effect for the quadriceps involved/uninvolved ratio but not for the hamstrings ratio. The BFRT group in the study by Takarada et al^[@bibr42-1941738118811337]^ had a significantly smaller percentage decrease in quadriceps CSA compared with the control group (9.4% and 20.7%, respectively; *P* \< 0.05; ES, --5.87) 15 days postoperatively; however, there was no between-group difference in the percentage decrease in hamstrings CSA. Iversen et al^[@bibr17-1941738118811337]^ reported no between-group difference in the percentage decrease in quadriceps CSA measured 16 days postoperatively.

Segal et al^[@bibr38-1941738118811337]^ detected negligible increases of quadriceps volume after 4 weeks of training women with knee osteoarthritis in both the BFRT and the control groups (1.3% and 0.01%, respectively). Giles et al^[@bibr11-1941738118811337]^ used ultrasound to measure quadriceps muscle thickness in patients with patellofemoral pain and reported minimal change in size in either group after 8 weeks of training. Ferraz et al^[@bibr8-1941738118811337]^ reported significant increases in CSA measured with computed tomography in both the BRFT group (7% increase; *P* \< 0.0001; ES, 0.39) and the high-resistance control group (8% increase; *P* \< 0.0001; ES, 0.54), but no change in the low-resistance control group.

Outcome Scales {#section19-1941738118811337}
--------------

Outcome instruments were used in 6 studies ([Table 4](#table4-1941738118811337){ref-type="table"}).^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr11-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337],[@bibr43-1941738118811337]^ Overall, significant improvements were reported in symptoms and function in both the BFRT and the control groups at the conclusion of these investigations, but few between-group differences were found. For instance, Bryk et al^[@bibr4-1941738118811337]^ reported significant improvements in the Lequesne scale after 6 weeks of training in both BFRT and control groups; however, the BFRT group had less anterior knee pain during training sessions. Giles et al^[@bibr11-1941738118811337]^ reported no differences between BFRT and control patients in the Kujala patellofemoral score after training, but the BFRT group reported a greater reduction in pain with daily activities (ES, 0.53).

###### 

Effect of training on outcome scales

![](10.1177_1941738118811337-table4)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                             BFRT Group   Control Group                                      
  -------------------------------------------- ----------------------------- ------------ --------------- --------- ------ ------ ---------- -----------------
  Tennent et al^[@bibr43-1941738118811337]^\   KOOS                                                                                          
  Knee arthroscopy                                                                                                                           

                                                Pain                         52.8         75.0            0.0001    69.4   77.8   0.04       NS

                                                Symptoms                     47.1         76.8            0.003     67.9   71.4   NS         NS

                                                ADL                          58.1         88.2            0.0009    73.5   75.0   NS         NS

                                                QOL                          31.3         59.3            0.003     43.8   62.5   NS         NS

                                                Sport                        10.0         47.5            0.0009    35.0   70.0   0.04       NS

                                               VR-12                                                                                         

                                                PCS                          0.86         46.3            0.001     36.5   47.7   0.04       NS

                                                MCS                          51.20        60.2            0.04      57.6   56.2   NS         0.01

  Segal et al^[@bibr37-1941738118811337]^\     KOOS                                                                                          
  Knee osteoarthritis, males                                                                                                                 

                                                Pain                         \~83         \~86            NS        \~76   \~81   NS         NS

  Segal et al^[@bibr38-1941738118811337]^\     KOOS                                                                                          
  Knee osteoarthritis, females                                                                                                               

                                                Pain                         \~80         \~82            NS        \~76   \~78   NS         NS

  Bryk et al^[@bibr4-1941738118811337]^\       Lequesne scale                11.5         6.5             0.001     13.0   7.0    0.001      NS
  Knee osteoarthritis                                                                                                                        

                                               VAS knee pain                 6.5          3.2             0.001     6.0    3.5    0.001      NS

                                               VAS knee pain with training   ---          2.5             ---       ---    6.2    ---        0.01

  Ferraz et al^[@bibr8-1941738118811337]^\     WOMAC                                                                HR     HR                
  Knee osteoarthritis                                                                                                                        

                                               Pain                          6.9          4.0             0.02      7.2    4.0    NS         NP

                                               Stiffness                     3.6          2.1             0.01      3.5    2.0    NS         NP

                                               Physical function             21.0         10.3            0.02      25.9   14.6   0.02       NP

                                               Total score                   31.5         17.1            0.008     36.6   21.2   0.02       NP

                                               WOMAC                                                                LR     LR                

                                               Pain                                                                 7.9    4.0    0.001      NP

                                               Stiffness                                                            2.8    1.8    NS         NP

                                               Physical function                                                    24.4   12.7   NS         NP

                                               Total score                                                          35.1   18.4   0.005      NP

  Giles et al^[@bibr11-1941738118811337]^\     Kujala patellofemoral score   73.6         86.5            \<0.001   72.6   83.2   \<0.001    NS, ES = 0.23
  Patellofemoral pain                                                                                                                        

                                               VAS worst pain                55.7         27.4            \<0.001   51.4   25.6   \<0.001    NS, ES = 0.27

                                               VAS ADL                       58.2         21.6            \<0.001   42.5   24.1   \< 0.001   0.02, ES = 0.53
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

ADL, activities of daily living; BFRT, blood flow--restricted training; ES, effect size; HR, high resistance; KOOS, Knee injury and Osteoarthritis Outcome Scores; LR, low resistance; MCS, mental component score; NP, not provided; NS, not significant; PCS, physical component score; QOL, quality of life; VAS, visual analog scale; VR-12, Veterans RAND 12-Item Health Survey; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

Recommendations for BFRT {#section20-1941738118811337}
------------------------

Overall, 6 of the 8 studies concluded BFRT was effective and should be considered after ACL reconstruction,^[@bibr29-1941738118811337],[@bibr42-1941738118811337]^ after routine knee arthroscopy,^[@bibr43-1941738118811337]^ in arthritic knees,^[@bibr4-1941738118811337],[@bibr38-1941738118811337]^ and in cases of patellofemoral pain ([Table 5](#table5-1941738118811337){ref-type="table"}).^[@bibr11-1941738118811337]^ Segal et al^[@bibr37-1941738118811337]^ found no benefit in 19 men with knee arthritis, and Iversen et al^[@bibr17-1941738118811337]^ reported unsatisfactory results in 12 patients after ACL reconstruction.

###### 

Overall results^[*a*](#table-fn7-1941738118811337){ref-type="table-fn"}^

![](10.1177_1941738118811337-table5)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                   Quadriceps Strength   Quadriceps CSA   Outcome Scales: Pain                            
  --------------------------------------------- ----- -------------------------------------------- --------------------- ---------------- ---------------------- ------------ ----- ----- -----
  Ohta et al^[@bibr29-1941738118811337]^\       210   Quadriceps, hamstrings, hip                  ---                   Yes              ---                    Yes          ---   ---   Yes
  ACL reconstruction                                                                                                                                                                      

  Takarada et al^[@bibr42-1941738118811337]^\   30    None                                         ---                   ---              Yes                    Yes          ---   ---   Yes
  ACL reconstruction                                                                                                                                                                      

  Iversen et al^[@bibr17-1941738118811337]^\    30    Quadriceps                                   ---                   ---              ---                    No           ---   ---   No
  ACL reconstruction                                                                                                                                                                      

  Tennent et al^[@bibr43-1941738118811337]^\    12    Quadriceps, hamstrings                       Yes                   Yes              ---                    ---          Yes   No    Yes
  Knee arthroscopy                                                                                                                                                                        

  Segal et al^[@bibr37-1941738118811337]^\      12    Quadriceps                                   No                    No               ---                    ---          No    No    No
  Knee osteoarthritis males                                                                                                                                                               

  Segal et al^[@bibr38-1941738118811337]^\      12    Quadriceps, hamstrings                       Yes                   Yes              No                     No           No    No    Yes
  Knee osteoarthritis females                                                                                                                                                             

  Bryk et al^[@bibr4-1941738118811337]^\        18    Quadriceps, hamstrings, hip, gastrocnemius   Yes                   No               ---                    ---          Yes   Yes   Yes
  Knee osteoarthritis                                                                                                                                                                     

  Ferraz et al^[@bibr8-1941738118811337]^\      24    Quadriceps                                   Yes                   Yes vs LR\       Yes                    Yes vs LR\   Yes   No    Yes
  Knee osteoarthritis                                                                                                    No vs HR                                No vs HR                 

  Giles et al^[@bibr11-1941738118811337]^\      24    Quadriceps                                   Yes                   No               No                     No           Yes   No    Yes
  Patellofemoral pain                                                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ACL, anterior cruciate ligament; BFRT, blood flow--restricted training; CSA, cross-sectional area; HR, high resistance; LR, low resistance.

--- = factor not analyzed in study.

Adverse Events {#section21-1941738118811337}
--------------

Adverse events related to BFRT were rarely encountered. Dropouts occurred due to discomfort with training in the series of Ohta et al^[@bibr29-1941738118811337]^ (2 of 24 \[8%\] enrolled) and Segal et al^[@bibr37-1941738118811337]^ (1 of 20 \[5%\] enrolled). No other adverse events were reported.

Discussion {#section22-1941738118811337}
==========

The limited published data show BFRT to be safe and potentially effective in improving quadriceps strength in patients with knee-related weakness and atrophy. There were no complications related to BFRT. Improvements in study design and refinements in protocols related to cuff pressure and exercise dosage and duration are required to further advance our knowledge of this treatment option.

The low-resistance load of 30% 1 RM used in 6 studies was effective in improving quadriceps strength without eliciting a pain response that may be incurred with high-load resistance levels. Ferraz et al^[@bibr8-1941738118811337]^ reported a dropout rate of 25% in patients in the high-resistance training control group due to exercise-induced knee pain. Few effects of training were noted in quadriceps CSA, and future data are required to determine whether changes in training dose or duration may improve this finding. Hamstrings strength was measured after training in only 2 studies,^[@bibr29-1941738118811337],[@bibr43-1941738118811337]^ and conclusions could not be reached regarding the efficacy of BFRT on this factor. One study that included isolated hamstrings exercises (reverse press) at 30% 1 RM reported an approximate 40% increase in hamstrings strength in the treatment group and a 17% increase in the control group.^[@bibr43-1941738118811337]^

The study protocols varied in cuff pressures selected for training, with pressures ranging from a mean of 97.4 mm Hg^[@bibr8-1941738118811337]^ to as high as 260 mm Hg (depending on patient tolerance^[@bibr42-1941738118811337]^). Only 4 studies provided information regarding cuff type and size.^[@bibr17-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337],[@bibr42-1941738118811337]^ Three studies set the pressure to a percentage of total arterial occlusal pressure. Patterson et al^[@bibr32-1941738118811337]^ recommended this type of approach to determine the appropriate blood flow--restricted pressure to minimize any cardiovascular risk and underlying tissue compression damage. These authors recommended using a handheld Doppler to make individual patient measurements and selected a range of 40% to 80% of limb occlusion for training. Four studies in our review gradually increased cuff pressure during training sessions or over the course of the study as tolerated. Systematic reviews of healthy participants have noted large variations in cuff pressure, as well as exercise doses and durations.^[@bibr21-1941738118811337],[@bibr25-1941738118811337],[@bibr36-1941738118811337],[@bibr41-1941738118811337]^ Slysz et al^[@bibr41-1941738118811337]^ included 47 studies of healthy participants in their review; muscular strength changes were available for 400 participants, and muscular hypertrophy data were available for 377 participants. The authors noted that no single cuff pressure produced equal blood flow restriction between participants and noted the need for the development of a model that would produce equal occlusion for all patients. With the data available, these authors recommended a cuff pressure of \>150 mm Hg, a resistance load of 30% 1 RM, and a training duration of at least 8 weeks to produce noteworthy increases in muscle strength and size. Others have recommended cuff pressures be individually adjusted based on cuff width, limb circumference, and composition of muscle and fat in the limb to produce equivalent blood flow restriction.^[@bibr22-1941738118811337],[@bibr35-1941738118811337]^ A recent study by Hughes et al^[@bibr14-1941738118811337]^ compared interface pressure, perceived exertion, and pain among 3 different blood flow restriction systems in 18 healthy male participants. The study concluded that a system that automatically adjusts pressure during exercise is most likely the most beneficial tool to use for patient tolerance and adherence to a BFRT program.

In our review, it appeared that a minimum of 12 sessions is required to achieve measurable strength gains. The time of cuff inflation in the other studies was typically 5 minutes, although 3 studies noted inflation of the cuff during exercise periods that were not timed. Further work is necessary to determine the appropriate cuff pressure and training dose and duration for rehabilitation of knee-related muscle atrophy and to determine whether a protocol similar to that used for healthy participants should be followed.

In healthy participants and athletes, BFRT has been shown to produce significant gains in muscle strength and hypertrophy^[@bibr21-1941738118811337],[@bibr25-1941738118811337],[@bibr36-1941738118811337],[@bibr41-1941738118811337]^; however, the underlying mechanisms responsible for these findings remain unclear.^[@bibr13-1941738118811337],[@bibr34-1941738118811337]^ The reduced blood flow is hypothesized to bring about an ischemic/hypoxic environment that increases levels of metabolic stress, increases recruitment of fast-twitch muscle fibers, elevates systematic hormones, induces cell swelling, and increases production of reactive oxygen species.^[@bibr13-1941738118811337],[@bibr34-1941738118811337]^ In addition, authors^[@bibr34-1941738118811337]^ have theorized that mechanical tension acts in a synergistic manner with metabolic stress to produce muscle hypertrophy. BFRT does not appear to induce acute skeletal muscle damage, as Loenneke et al^[@bibr24-1941738118811337]^ noted in a review of studies that reported no prolonged decrements in muscle function or swelling and no elevation in blood biomarkers of muscle damage. Mechanisms for potential improvements in quadriceps and hamstrings strength in patients with knee-related muscle atrophy after BFRT are unknown at present.

A few small case series were found in this systematic review that assessed the effects of BFRT after total knee arthroplasty (3 patients)^[@bibr10-1941738118811337]^ and in patients with chronic atrophy after lower extremity trauma (7 patients).^[@bibr15-1941738118811337]^ The results were encouraging, with all patients demonstrating improvements in isokinetic strength and no complications reported. Although these series were not included in our formal review, the positive results provide further evidence of the safety and efficacy of this training to augment traditional rehabilitation protocols.

One problem highlighted in this review is that only 2 studies provided ES calculations in addition to *P* values. ES measures the magnitude of the effects of treatment and is especially relevant in studies with small sample sizes.^[@bibr9-1941738118811337]^ It is probable that some statistically significant findings (*P* \< 0.05) may have limited clinical relevance. The question of what percentage of muscle strength gain from BFRT represents a minimal clinically important difference (MCID)^[@bibr18-1941738118811337]^ remains questionable. In musculoskeletal disorders, this may be influenced by the diagnosis and magnitude of muscle weakness and atrophy. For instance, one may arbitrarily set a value of strength gain of 10% as the MCID; however, if a deficit of quadriceps peak torque between limbs at baseline is 50%, a 10% gain in strength may not be clinically meaningful to the patient. An additional problem detected in this review was the sample size selected in many studies. Only 4 studies^[@bibr4-1941738118811337],[@bibr8-1941738118811337],[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ conducted a prospective power calculation of the size required to discern a detectable difference (95% CI) between BFRT and control groups. Future studies should calculate both ESs and sample sizes to minimize the occurrence of a type II statistical error.^[@bibr12-1941738118811337]^ Another problem noted in our review was the lack of consistency in reporting muscle strength data. One study^[@bibr29-1941738118811337]^ provided only limb ratios (involved/uninvolved limb), and another study^[@bibr37-1941738118811337]^ reported only the percentage change from baseline values of knee extensor strength. Future studies should report the peak torque values at baseline and follow-up and normalize all data by body weight.

A history of deep venous thrombosis was considered a contraindication for training in the investigations of Segal et al.^[@bibr37-1941738118811337],[@bibr38-1941738118811337]^ Giles et al^[@bibr11-1941738118811337]^ excluded patients at elevated risk of deep vein thrombosis (lower limb surgery within the previous 6 months, cardiovascular conditions, or high blood pressure). Tennent et al^[@bibr43-1941738118811337]^ performed bilateral lower extremity duplex ultrasounds before and on completion of their investigation, to rule out vascular problems. All studies were negative, and no adverse events were reported. In the study by Bryk et al,^[@bibr4-1941738118811337]^ a vascular surgeon assessed femoral and tibial pulses to exclude potential vascular risks before patients were entered in the trial. Hughes et al^[@bibr13-1941738118811337]^ reviewed 20 studies of BFRT used for musculoskeletal rehabilitation and reported few to no adverse events reported. The conclusion was made that correct implementation of this training option presents no greater risk than traditional training modes.^[@bibr26-1941738118811337]^

Conclusion {#section23-1941738118811337}
==========

Published data show BFRT to be potentially effective in improving quadriceps strength in patients with knee-related weakness and atrophy. The use of short-duration vascular occlusion and low-load resistance exercises appears safe and not deleterious after knee surgery or in arthritic knees. This treatment option requires further investigation to refine protocols related to cuff pressure and exercise dosage and duration.
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